Chasing Shadows, Catching Smoke, and Estimating Anaphylaxis to Sugammadex
- PMID: 33315606
- DOI: 10.1213/ANE.0000000000005192
Chasing Shadows, Catching Smoke, and Estimating Anaphylaxis to Sugammadex
Comment on
-
Incidence of Anaphylaxis to Sugammadex in a Single-Center Cohort of 19,821 Patients.Anesth Analg. 2021 Jan;132(1):93-97. doi: 10.1213/ANE.0000000000004752. Anesth Analg. 2021. PMID: 32243295
References
-
- Burbridge M. Incidence of anaphylaxis to sugammadex in a single center cohort of 19,821 patients. Anesth Analg. 2021;132:93–97.
-
- Min KC, Bondiskey P, Schulz V, et al. Hypersensitivity incidence after sugammadex administration in healthy subjects: a randomised controlled trial. Br J Anaesth. 2018;121:749–757.
-
- Miyazaki Y, Sunaga H, Kida K, et al. Incidence of anaphylaxis associated with sugammadex. Anesth Analg. 2018;126:1505–1508.
-
- Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report–second national institute of allergy and infectious disease/food allergy and anaphylaxis network symposium. J Allergy Clin Immunol. 2006;117:391–397.
-
- Corda D, Gravenstein N. Sugammadex: the anaphylactic risk. Anesthesia Patient Safety Foundation Newsletter. 2018;33
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
